<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

BioMedGPS Announces Expansion of SmartTRAK Business Intelligence to the Neuromodulation and Neurovascular Markets

Posted by Anne Staylor on 1/25/17 5:46 PM

January 25, 2017 02:46 PM Eastern Standard Time

IRVINE, Calif.--()--BioMedGPS, the leading provider of real-time business analytics and analysis of the orthopedic/spine, wound care and regenerative medicine markets, announces expanded coverage of SmartTRAK Business Intelligence to the Neuro Therapies market with the introduction of SmartTRAK Neuromodulation and SmartTRAK Neurovascularmodules.

SmartTRAK Neuromodulation ModuleThe newest SmartTRAK modules, SmartTRAK Neuromodulation and SmartTRAK Neurovascular, provide up-to-date market data on all of the companies and products in the spinal cord stimulator and mechanical thrombectomy segments as well as innovative tools to help medical device executives track and assess competitive developments in these fields.

Anne Staylor, Managing Editor, SmartTRAK Business Intelligence, will be introducing the new SmartTRAK Neuromodulationmodule during a webinar to be held on Tuesday, January 31st at 2:00 pm EST. This module provides detailed analysis and insight into the $1.4 Billion US spinal cord stimulator market including 5-year forecasts, procedural data, competitive shares, market and technology trends, emerging indications, company and product profiles, patents, clinical trials, deals/financings, regulatory, reimbursement, earnings calls, analyst Anne Staylor SmartTRAK Editor NeuroModulation.jpgperspectives, and more.

To register for the anuary 31st, 2017 webinar, please go to https://www.biomedgps.com/smarttrak-webex 

SmartTRAK is a comprehensive, easy-to-use, web-based business intelligence solution that networks an entire organization with real-time market data and analysis, fostering an innovative collaborative approach to market strategy and driving better decisions,” reports Sharon O’Reilly, President & CEO of BioMedGPS. “Currently used by the 10 top Orthopedic/Spine implant manufacturers and 8 of the top 10 Wound Care companies, SmartTRAK transforms the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity, and reduce cost.”

SmartTRAK Neurovascular Module.jpgUnlike static market reports, SmartTRAK monitors and updates critical market information daily in real time. Every SmartTRAK module is managed by seasoned industry analysts with more than 10 years’ experience in marketing, competitive intelligence or business development with major medical device corporations

including J&J, Stryker, Smith & Nephew, 3M, AlloSource, Mölnlycke, among others.

Other currently available SmartTRAK modules include:

  • Orthopedics: Total Joints, Extremities, Trauma, OrthoBio, Soft Tissue Fixation, Spine
  • Wound Care: Wound Biologics, Negative Pressure Wound Therapy, Advanced Dressings, Diagnostic Aids, Compression, Vascular Access
  • Regen Medicine: Amniotic Tissue, Cell Processing, Surgical Matrices (Hernia and Breast Repair)

About BioMedGPS

BioMedGPS is a privately held company founded in 2010 by Sharon O’Reilly, the founder and former President & CEO of Medtech Insight.

 Contacts

BioMedGPS / SmartTRAK

Anne Staylor, 949-559-5511, anne.staylor@biomedgps.com
SmartTRAK.com

Topics: Neurotherapies

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts